chrisvoncsefalvay/vaers-outcomes huggingface dataset:
felt lousy; brain fog; sweaty feet; head pain; shooting pain going across her head, from the base of her neck up to the middle of her and also around the top of head; Dry cough; Runny nose; Hair loss; Memory loss; they had fatigue, fatigue in arm,; strange sensation in the nerves; inappropriate schedule of vaccine administered; This is a spontaneous report from a contactable consumer (patient's daughter). A 86-years-old female patient received second dose of bnt162b2 (Solution injection; Batch/Lot Number: EL9266), via an unspecified route of administration, administered in Arm Left on 23Feb2021 (at the age of 86-years-old) as single dose for covid-19 immunisation. Medical history included lung cancer. She has been on chemo for about 5 years now. The patient's concomitant medications included osimertinib mesilate (TAGRISSO), amlodipine besilate for blood pressure and some vitamins. Patient previously received first dose of bnt162b2 (Solution injection; Batch/Lot Number: EL3302), via an unspecified route of administration, administered in Arm Left on 06Feb2021 as 225mcg/0.45mL single dose for covid-19 immunisation. The patient experienced brain fog, sweaty feet, dry cough, runny nose, hair loss, memory loss. Caller reported that the patient felt lousy and had all these strange happenings. She had head pain; shooting pain going across her head, from the base of her neck up to the middle of her and also around the top of head. It was like this strange sensation in the nerves. It was like a tension headache that where a part of it didn't materialize. Caller stated that they had fatigue, fatigue in arm. Caller questioned if the patient should get an antibody test to see if she still has some antibodies. The outcome of all the events was recovered.  Follow-Up (01Sep2021): Follow-up attempts are completed. No further information is expected.
shot on March 4th. shot site stiff for 36 hours ( not bad). then?.elbow pain in OTHER arm and next morning, no strength in the arm or hand. and?.all joints and tendons from below shoulder hurt (wrist especially). burning sensation in forearm or upper arm at times.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient's healthcare provider recommended and/or prescribed the ZOSTAVAX vaccine to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. On 26-APR-2013, a healthcare provider administered the ZOSTAVAX to the patient (lot number, dosage and route of administration not provided). On 14-JUN-2015, the patient was treated by a healthcare provider for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX vaccine, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions (unspecified); lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was considered to be not recovered. Additional information has been requested.
Woke up with a severe migraine (so bad it induced vomiting most of day).  Probably began about 12-14 hours after the injection.  Lasted into evening.  One of my most severe migraines and definitely the longest lasting
BlurredVision, Myalgia, Fever, NauseaVomiting, wobbly legs, difficulty standing Narrative:  Headache was immediate from receiving the vaccine, felt really hot while at work, felt like her vision was blurry, then later that evening, felt legs were wobbly, was having difficulty standing, vomiting, fever of 102F. Took Excedrin for her headache which did not help much, typically gets migraines.
having a lot of chills; muscle aching; Joint aching; injection site is swollen; injection site hurts very badly; A spontaneous report was received from a 30-year-old, female patient who received Moderna's COVID-19 Vaccine (mRNA-1273) and experienced having a lot of chills, muscle aching, joint aching, injection site is swollen and injection site hurts very badly.  The patient's medical history was not provided. No relevant concomitant medications were reported.   On an unknown date in Dec 2020, the patient received the first of two planned doses of mRNA-1273 (Batch number: 025L20A) in her right arm for prophylaxis of COVID-19 infection.  On 30-Dec-2020, the patient reported that she was experiencing some side effects after taking the vaccine. She stated she was having a lot of chills, muscle and join aching, and that the injection site was swollen and hurts very badly.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.  The outcomes of the events, having a lot of chills, muscle aching, join aching, injection site is swollen, and injection site hurts very badly, were considered unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
low grade fever 99.3 x 14 hrs with chills and body aches, general malaise
My arm got very achy and my legs got achy; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date not reported), via an unspecified route of administration on 26Jan2021 as single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that the patient's arm got very achy and legs got achy on an unspecified date and took paracetamol (TYLENOL) as treatment. The patient was asking regarding taking paracetamol after the shot since when the patient got home, heard on the news that you were not supposed to take paracetamol or anything after having the shot. The patient was given some literature with a shot and read over and got the shot and it was not written in the literature. The outcome of the event was unknown.  Follow-up attempts are completed. No further information is expected.
Sore arm pain spanning for two days; consist headaches; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Sore arm pain spanning for two days) and HEADACHE (consist headaches) in a 21-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Apr-2021, the patient experienced HEADACHE (consist headaches). On an unknown date, the patient experienced ARTHRALGIA (Sore arm pain spanning for two days). The patient was treated with ACETAMINOPHEN for Symptomatic treatment, at an unspecified dose and frequency. At the time of the report, ARTHRALGIA (Sore arm pain spanning for two days) and HEADACHE (consist headaches) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.
The baby was constipated Monday, Tuesday, and Wednesday (10/23 to 10/25). The vaccine was given 10/25. Diarrhea occurred in the patient on 10/26, lasted until 11/4 (10 oz were lost). The infant's diaper was changed every 1/2 hour, sometimes as frequently as 20 minutes. No other family member was sick. The patient has a 20 month old brother. The vaccine should have been DTaP (3rd dose) but the vaccine was drawn up wrong. The doctor wanted to revaccinate on 11/1 when the patient was brought in because of diarrhea and weight loss.
Patient received the 1st dose on 21-AUG- 2020. The patient has not yet received the 2nd dose, is late due to the pandemic.; This case was reported by a pharmacist via call center representative and described the occurrence of social problem in a 71-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included shingrix (1st dose received on 27th August 2020).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced social problem. On an unknown date, the outcome of the social problem was unknown.   Additional Information: GSK Receipt Date: 8-JUN-2022 Reporter's Comments: The pharmacist reported that a patient received the first dose of Shingrix on 27th August 2020. The patient was late due to the pandemic. The patient had not yet received the second dose. The reporter did not consent to follow-up. The pharmacist said that follow-up via phone call would be okay (declined postal or email).
it is now almost a year since the health department offered influenza and pneumonia shots. I received mine on 11/08/01. I was a healthy person who walked 2 miles a day, strong back, strong bones and muscles. Since the shots, I've been crippled with sciatica up to mid-September of this year, and left with a weakened back forever. The shots were particularly painful. For two nights, I ran a fever, and for a week, could not turn in bed for the pain of rolling onto either shoulder. Within two to three weeks, my feet felt peculiar, as if with a circulation problem. A daily two-mile walk did not clear the sensation. Then something was starting to happen in my lower back. There started to be a twinge in the lumbar region with every step. I attributed it to the vaccine shots, and trusted it to wear off. But it got worse. As luck would have it, in March this year I was treated to a massage by a licensed physical therapist. She believed I had sciatica. By then, I was having trouble getting out of bed and trying to walk, and could only do so by bending over and limping onto my good right leg. For seven months I could sleep only on my right side in the fetal position. Frequency became a problem, not only as if an internal pressure or swelling were the cause, but the sheer pain of trying to get to the bathroom, sometimes crawling, three or four times a night was a nightmare. By May, and the next several months, I was crippled with pain in a very limited life. A neighborhood doctor prescribed Darvocet and rest. I did not open the bottle. A friend insisted that I have chelation. Another doctor was assigning me to get an epidural cortisone shot. Instead, I went to a health food store to ask if there was a product able to remove toxins from the body. A jar of Liverclean and another of ecchinacea was suggested. I asked my doctor to assign me to a physical therapy clinic where the first two weeks in September consisted of electrical stimulation and heat. These did nothing. I managed to walk in, but departed, limping. I asked to use the machines, especially the stationary bicycles. Miraculously, the sciatica in my left leg was gone in two weeks after doing these work outs and dosing with the detox formula. As an uneducated guess, I suspect the vicious neurotoxin, mercury, in the two vaccine shots as having gone directly to the nerve center and attacking the soft tissue of the L4-L5 vertebrae (shown in MRI) in my spine. The best response from three doctors, when asked about mercury, was that I must be allergic to mercury. Even though I'm free of sciatica, there is permanent damage done to my spine. I now must move cautiously, carefully load and unload groceries, get in or out of the car, avoiding twisting while bending, or pushing a sweeper, mop , or vacuuming. Walking at my old pace is no longer possible, and standing for any length of time begins to hurt. I am grateful, however, for finally being able to sleep on either my left or right sides.
24 hours after flu shot patient began having an itchy, burning rash on her back and stomach.
27JAN93 1PM recvd Hep B inject #1 145PM started having cold chills, cramping; 205PM diarrhea started; 28JAn93 started w/diarrhea; stomach cramps;
This spontaneous report as received from a Medical Assistant refers to unspecified number of patients. On an unknown date the patients were vaccinated with doses of ZOSTAVAX (lot#, strength, dosage, route unknown). On 14-MAR-2014 the reporter reported a temperature excursion. Since the excursion that was reported, some of these doses of ZOSTAVAX had been administered to patients. The healthcare worker did not report an adverse experience. This is one of several reports received from the same reporter. Additional information has been requested.
Red rash at site of injection and surrounding 3-4 inches of arm.  Small amount of swelling at site of injection and surrounding area.  Itching.
lethargic, pain both eyes & ears; redened rash on neck, chest, abdo & behind ears; diarrhea & abdo pain present; mom states questionable egg allergy; t 104 for 2 days;
Sore at injection site, used rubbing alcohol. Felt better after a few rubs. Nausea, a few days after, drank tea and honey. Came and left for a couple days Slight headache the next day, did not take anything. Meditation, Cramps in pelvic area, did stretches and yoga.
Left upper arm numb and required assistance to move..  Patient went to doctor a received prescriptions for  diclofenac and tizandine. Patient was told the injection was given to high on the arm and the needle hit a nerve and possibly the bone. Symptoms resolved on 11/2/20.
Mother sts pt has a red, itchy, rash at the site of administration, left deltoid.  Per the mother pt has been administered Benadryl for the past two days on as of today, 2/18/2015, the site is clearing up.
I got vaccine around 11am Saturday morning. When I woke up Sunday, I had a severe headache. I took two Tylenol, watched some TV then took a 2-hour nap around 4pm. I still had a headache when I awoke. I took two more Tylenol. When I woke up Monday morning I still have a pounding headache. I took two Advil. An hour later I still have a headache. I spoke to pharmacist and she advised me to report my symptoms.
Information has been received from a company representative concerning her 15 year old daughter with asthma and no drug reactions/allergies who on 02-APR-2009 was vaccinated with the first 0.5ml dose of GARDASIL IM. On 29-DEC-2009 the patient was vaccinated with the third 0.5ml dose of GARDASIL (lot# 663452/0671Y) IM. Concomitant therapy included YAZ. On 29-DEC-2009, 45 minutes after receiving her third dose of vaccination, the patient developed widespread hives, as well as lip and eyelid swelling. There were no respiratory symptoms. The patient was seen by the doctor in the office. No laboratory diagnostic studies were performed. The patient was treated with ATARAX and prednisone in the office and the symptoms resolved within 2 hours. At the time of the report, the patient recovered. Additional information has been requested.
Patient started to have severe tremors which then caused muscle aches. She couldn't sleep so she got up to read and then suddenly vomited. In the morning she was left with a deep cough, dizziness, and fatigue. Also has local redness and itching.
8 by 10 cm  area surrounding injection site of Left Deltoid.   Warmth, redness, and itching at the side of injection.
Initial report received on 09 October 2013 from a health care professional. A 57-year-old female patient whose medical history and concomitant medications were not reported, received a dose of FLUZONE ID (lot number UT47119AA, expiration date unknown) by intradermal route and site of vaccination was deltoid 07-Oct-2013. It was reported that a patient over 57-year-old have received the FLUZONE ID. As of 08-Oct-2013, patient had 5.5 inch area of induration surrounding injection site with redness and warmth. No treatment prescribed. No physician evaluation. No self-treatment. Patient reported over time site has improved. List of documents held by sender: none.
Janssen COVID-19 Vaccine A - body aches, fever reaching 102.3 for several hours, severe headache, all starting about 17 hours after shot and lasting about 22 hours.
Patient received second dose of Pfizer without diluent. PCP will be contacting patients parents to discuss. Unknown if patient had any adverse events and or side effects.
States that it was worse the second day; States that her wife is afraid to take the second dose of the Pfizer Covid 19 Vaccine; Experiencing pain in her arm after receiving the 1st dose; This is a spontaneous report from a contactable consumer. This consumer (patient's wife) reported for a female (patient). A 28-year-old female patient received bnt162b2 (BNT162B2, solution for injection, Lot number: Unknown, Expiry date: Unknown, NDC number: Unknown) dose 1 via an unspecified route of administration, administered in the left arm on 17Jul2021 16:45 (at the age of 28 years old) as dose 1, single for COVID-19 immunisation. Medical history included ongoing oesophageal achalasia, ongoing cardiac murmur functional, diabetes (aunt with diabetes). The patient concomitant medication was not reported. No PQC was present. Vaccine was not administered at facility. No other vaccines were given 4 weeks. Additional vaccines were not administered on same date of the pfizer suspect. On 17Jul2021 the patient experienced experiencing pain in her arm after receiving the 1st dose. On an unspecified date Patient states that it was worse the second day, states that her wife is afraid to take the second dose of the pfizer covid 19 vaccine. Reporter states that the caller's wife's second dose of the vaccine is scheduled for 07Aug2021. The caller would like to know if this side effect was normal and if her wife can still take the second dose when she is still having pain; mentions the pain is not as bad now as it was in the first days. Caller comes onto the line and verifies information received from the transferring agent. States that her wife is afraid to take the second dose of the Pfizer Covid 19 Vaccine. Says her wife has heard that sometimes the second dose was worse than the first one. State's wife was worried because she was still feeling the arm pain from the first one. Caller mentions that her wife has a condition called Achalasia. States that are causes difficulty swallowing and was a rare disease with no cure. Caller states her wife was diagnosed with this about 2 months ago. States her wife was diagnosed before she received the first dose of the vaccine. Caller mentions that the vaccine was the same for her. She also had pain in her arm. States she had this with her first and second dose. With the second dose she states she also had fever and pain all over her body. Caller states she knew this was normal. Caller states that she is good and declines to complete a safety report for herself currently. Caller states she has no questions regarding her own experience. AE had not result to emergency and physician room visit. The clinical outcome of the event experiencing pain in her arm after receiving the 1st dose was reported as not recovered and states that it was worse the second day, states that her wife is afraid to take the second dose of the pfizer covid 19 vaccine was reported as unknown.
elevated heart rate, difficulty catching breath, violent shaking, stabbing pains in joints and organs, inability to sleep, dehydration, hot and cold chills, headache.
Called MD on call. Swelling & hives hands & arms bil. Were starting to look purple. Face & body five red bumps, itchy feet bright red. Took Allegra & went to ER. as advised
No additional AE reported; A 26 month old patient received the first dose of PROQUAD on 27-JUN-2022, and then received a second dose of PROQUAD on 13-JUL-2022; This spontaneous report has been received from a clinical manager referring to a 26-month-old patient of unknown gender. The patient's pertinent medical history, concurrent conditions, drug reactions or allergies, and concomitant medications were not provided.  On 27-JUN-2022, the patient was vaccinated with the first dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) for prophylaxis, 0.5 milligram (mg), (lot number W004026 had been verified to be a valid number; expiration date was reported as 02-AUG-2019, and upon internal validation established as the same date) (strength, anatomical location, and route of administration were not provided). Additionally, on 13-JUL-2022, the patient was inadvertently given, earlier than recommended, a second dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) for prophylaxis, 0.5 milligram (mg), (lot number W004026 had been verified to be a valid number; expiration date was reported as 02-AUG-2019, and upon internal validation established as the same date) (strength, anatomical injection, and route of administration were not provided) (inappropriate schedule of vaccine administered).  No adverse event reported.
Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 3/13/2021 and 4/3/2021.  Patient presented to ED on 11/5/2021 with 1 day worsening of shortness of breath and labored breathing. Patient increased home 0xygen from 2L to 5L, with pulse ox readings in the 60s while on the 5L. Oxygen requirements escalated over following days. Patient's COVID treated with dexamethasone, remdesivir and antibiotics. Intubated on day 9 of admission. Resuscitation efforts limited to intubation only per patient request.  Expired on 11/18/2021.
This is one case in a series of 12 cases received during the surveillance period from 01 January 2010 to 21 January 2011. Initial report received on 21 January 2011 from the Investigator participating in the above-mentioned post-marketing observational surveillance study under the reference number M5A16. A case of pertussis disease in a four-year-old female subject (initial not collected) was identified by the investigator based on review of data. The subject's vaccine history included 2 doses of TRIPEDIA; lot number U1891BA received on 06 September 2006 and lot number U1813BA received on 01 November 2006; and 2 doses of DAPTACEL; lot number C2552AA received on 12 January 2007 and lot number C2799AA received on 13 February 2008 (routes and sites of administration not reported). The subject developed cold-like symptoms, and on 21 August 2010, approximately 30 months after the last dose, she developed a paroxysmal cough without whoop or posttussive vomiting. The subject also experienced sleep disturbance. Laboratory testing included positive PCR on 03 September 2010. Chest x-ray findings were negative for pneumonia. Corrective treatment consisted of Azithromycin for 5 days starting on 03 September 2010. The subject was not hospitalized. At the time of final contact on 01 November 2010, the subject's cough had been resolved. The duration of the cough was reported at that time as 53 days. Investigator causality assessment is not reported as per protocol. Documents held by sender: None.
Headache, Myalgia & NauseaVomiting Narrative: Headache, chills, body aches, vomiting, nausea